Found: 116
Select item for more details and to access through your institution.
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non–Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1084, doi. 10.4143/crt.2024.084
- By:
- Publication type:
- Article
Impact of EGFR mutation on the clinical efficacy of PD-1 inhibitors in patients with pulmonary adenocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 5, p. 1341, doi. 10.1007/s00432-019-02889-0
- By:
- Publication type:
- Article
Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 8, p. 1203, doi. 10.1007/s00432-011-0986-0
- By:
- Publication type:
- Article
The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 4, p. 687, doi. 10.1007/s00432-010-0928-2
- By:
- Publication type:
- Article
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 532, doi. 10.1002/cpdd.427
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery.
- Published in:
- Journal of Korean Neurosurgical Society, 2021, v. 64, n. 2, p. 271, doi. 10.3340/jkns.2020.0135
- By:
- Publication type:
- Article
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer.
- Published in:
- European Journal of Immunology, 2021, v. 51, n. 4, p. 956, doi. 10.1002/eji.202048966
- By:
- Publication type:
- Article
MDSC subtypes and CD39 expression on CD8<sup>+</sup> T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC.
- Published in:
- European Journal of Immunology, 2020, v. 50, n. 11, p. 1810, doi. 10.1002/eji.202048534
- By:
- Publication type:
- Article
Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 5, p. 594, doi. 10.1093/jjco/hyaa019
- By:
- Publication type:
- Article
Different clinical outcomes between locally advanced hypopharyngeal and oropharyngeal cancer treated with definitive concurrent chemoradiotherapy: implication for subgroup selection for induction chemotherapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 1, p. 40, doi. 10.1093/jjco/hyv163
- By:
- Publication type:
- Article
Practice pattern and risk of not receiving planned surgery after neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2024, v. 66, n. 1, p. 1, doi. 10.1093/ejcts/ezae253
- By:
- Publication type:
- Article
Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With MET Exon 14 Skipping.
- Published in:
- In Vivo, 2020, v. 34, n. 3, p. 1399, doi. 10.21873/invivo.11920
- By:
- Publication type:
- Article
Pretreatment Clinical Mediastinal Nodal Bulk and Extent do not Influence Survival in N2-Positive Stage IIIA Non-small Cell Lung Cancer Patients Treated with Trimodality Therapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 6, p. 2083, doi. 10.1245/s10434-014-3540-x
- By:
- Publication type:
- Article
Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea.
- Published in:
- 2020
- By:
- Publication type:
- journal article
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 265, doi. 10.1007/s10637-021-01121-6
- By:
- Publication type:
- Article
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 360, doi. 10.1007/s10637-019-00795-3
- By:
- Publication type:
- Article
Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 782, doi. 10.1007/s10637-017-0463-y
- By:
- Publication type:
- Article
AZD9291 overcomes T790 M-mediated resistance through degradation of EGFR in non-small cell lung cancer cells.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 4, p. 407, doi. 10.1007/s10637-016-0350-y
- By:
- Publication type:
- Article
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 1, p. 12, doi. 10.1007/s10637-014-0163-9
- By:
- Publication type:
- Article
Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Programmed Death Ligand 1 Expression in Paired Non-Small Cell Lung Cancer Tumor Samples.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Vertical Magnetic Separation of Circulating Tumor Cells for Somatic Genomic-Alteration Analysis in Lung Cancer Patients.
- Published in:
- Scientific Reports, 2016, p. 37392, doi. 10.1038/srep37392
- By:
- Publication type:
- Article
Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase II Study.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 2, p. 567, doi. 10.4143/crt.2023.897
- By:
- Publication type:
- Article
Expanded Access Program Pralsetinib in Advanced Non-Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1144, doi. 10.4143/crt.2023.403
- By:
- Publication type:
- Article
First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: Real-World Data.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 1, p. 61, doi. 10.4143/crt.2023.461
- By:
- Publication type:
- Article
EGFR Mutation-Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 498, doi. 10.4143/crt.2022.388
- By:
- Publication type:
- Article
The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 479, doi. 10.4143/crt.2022.1344
- By:
- Publication type:
- Article
Long-term Survival in Non-Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive Treatment.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 1, p. 150, doi. 10.4143/crt.2021.306
- By:
- Publication type:
- Article
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1288, doi. 10.4143/crt.2020.278
- By:
- Publication type:
- Article
Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 1, p. 292, doi. 10.4143/crt.2019.186
- By:
- Publication type:
- Article
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 493, doi. 10.4143/crt.2018.125
- By:
- Publication type:
- Article
Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 623, doi. 10.4143/crt.2018.151
- By:
- Publication type:
- Article
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 502, doi. 10.4143/crt.2018.117
- By:
- Publication type:
- Article
Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-Mutated Non-small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 1, p. 408, doi. 10.4143/crt.2018.138
- By:
- Publication type:
- Article
Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 1, p. 95, doi. 10.4143/crt.2016.591
- By:
- Publication type:
- Article
Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 4, p. 880, doi. 10.4143/crt.2016.442
- By:
- Publication type:
- Article
Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 4, p. 906, doi. 10.4143/crt.2016.424
- By:
- Publication type:
- Article
Association between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 2, p. 527, doi. 10.4143/crt.2015.249
- By:
- Publication type:
- Article
Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 4, p. 645, doi. 10.4143/crt.2014.144
- By:
- Publication type:
- Article
Tumor Lysis Syndrome in a Solid Tumor: A Case Report of a Patient with Invasive Thymoma.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064816
- By:
- Publication type:
- Article
<i>EGFR</i> Mutation Testing in Patients with Advanced Non-Small Cell Lung Cancer: A Comprehensive Evaluation of Real-World Practice in an East Asian Tertiary Hospital.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056011
- By:
- Publication type:
- Article
Utility of positron emission–computed tomography for predicting pathological response in resectable oesophageal squamous cell carcinoma after neoadjuvant chemoradiation.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2020, v. 58, n. 5, p. 1019, doi. 10.1093/ejcts/ezaa181
- By:
- Publication type:
- Article
Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03852-w
- By:
- Publication type:
- Article